Literature DB >> 9560188

Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor.

J Lubkowski1, F Yang, J Alexandratos, A Wlodawer, H Zhao, T R Burke, N Neamati, Y Pommier, G Merkel, A M Skalka.   

Abstract

The x-ray structures of an inhibitor complex of the catalytic core domain of avian sarcoma virus integrase (ASV IN) were solved at 1.9- to 2.0-A resolution at two pH values, with and without Mn2+ cations. This inhibitor (Y-3), originally identified in a screen for inhibitors of the catalytic activity of HIV type 1 integrase (HIV-1 IN), was found in the present study to be active against ASV IN as well as HIV-1 IN. The Y-3 molecule is located in close proximity to the enzyme active site, interacts with the flexible loop, alters loop conformation, and affects the conformations of active site residues. As crystallized, a Y-3 molecule stacks against its symmetry-related mate. Preincubation of IN with metal cations does not prevent inhibition, and Y-3 binding does not prevent binding of divalent cations to IN. Three compounds chemically related to Y-3 also were investigated, but no binding was observed in the crystals. Our results identify the structural elements of the inhibitor that likely determine its binding properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560188      PMCID: PMC20173          DOI: 10.1073/pnas.95.9.4831

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  Genetics of retroviral integration.

Authors:  S P Goff
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

2.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.

Authors:  S A Chow; K A Vincent; V Ellison; P O Brown
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

3.  Retroviral integrase domains: DNA binding and the recognition of LTR sequences.

Authors:  E Khan; J P Mack; R A Katz; J Kulkosky; A M Skalka
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

4.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

Authors:  A T Brünger
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

Review 5.  The retroviral enzymes.

Authors:  R A Katz; A M Skalka
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

6.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 7.  Aromatic-aromatic interaction: a mechanism of protein structure stabilization.

Authors:  S K Burley; G A Petsko
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

8.  The DNA-binding domain of HIV-1 integrase has an SH3-like fold.

Authors:  A P Eijkelenboom; R A Lutzke; R Boelens; R H Plasterk; R Kaptein; K Hård
Journal:  Nat Struct Biol       Date:  1995-09

9.  Solution structure of the DNA binding domain of HIV-1 integrase.

Authors:  P J Lodi; J A Ernst; J Kuszewski; A B Hickman; A Engelman; R Craigie; G M Clore; A M Gronenborn
Journal:  Biochemistry       Date:  1995-08-08       Impact factor: 3.162

10.  High-resolution structure of the catalytic domain of avian sarcoma virus integrase.

Authors:  G Bujacz; M Jaskólski; J Alexandratos; A Wlodawer; G Merkel; R A Katz; A M Skalka
Journal:  J Mol Biol       Date:  1995-10-20       Impact factor: 5.469

View more
  23 in total

1.  Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein.

Authors:  J Y Wang; H Ling; W Yang; R Craigie
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.

Authors:  Marta Nadal; Philippe J Mas; Phillipe J Mas; Alexandre G Blanco; Carme Arnan; Maria Solà; Darren J Hart; Miquel Coll
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

3.  Computational investigation of the anti-HIV activity of Chinese medicinal formula Three-Huang Powder.

Authors:  Jack Z Hu; Li Bai; Da-Gang Chen; Qi-Tai Xu; William M Southerland
Journal:  Interdiscip Sci       Date:  2010-05-01       Impact factor: 2.233

4.  Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.

Authors:  Mathieu Métifiot; Kasthuraiah Maddali; Alena Naumova; Xuemin Zhang; Christophe Marchand; Yves Pommier
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

5.  Coupling between catalytic site and collective dynamics: a requirement for mechanochemical activity of enzymes.

Authors:  Lee-Wei Yang; Ivet Bahar
Journal:  Structure       Date:  2005-06       Impact factor: 5.006

6.  Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.

Authors:  Laith Q Al-Mawsawi; Valery Fikkert; Raveendra Dayam; Myriam Witvrouw; Terrence R Burke; Christoph H Borchers; Nouri Neamati
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

7.  Prediction of the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approach.

Authors:  Zengjian Hu; Dagang Chen; Lanxiang Dong; W M Southerland
Journal:  Ethn Dis       Date:  2010       Impact factor: 1.847

8.  A three-dimensional model of the human immunodeficiency virus type 1 integration complex.

Authors:  Jerome Wielens; Ian T Crosby; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

9.  Rigidity and flexibility characteristics of DD[E/D]-transposases Mos1 and Sleeping Beauty.

Authors:  Christopher M Singer; Diana Joy; Donald J Jacobs; Irina V Nesmelova
Journal:  Proteins       Date:  2019-01-10

Review 10.  Piecing together the structure of retroviral integrase, an important target in AIDS therapy.

Authors:  Mariusz Jaskolski; Jerry N Alexandratos; Grzegorz Bujacz; Alexander Wlodawer
Journal:  FEBS J       Date:  2009-04-14       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.